Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Arintra $25M Series BOxide Computer Company $200M Series CRanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Arintra $25M Series BOxide Computer Company $200M Series CNew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Agentrys $24.5M Pre-Seed+SeedConvex $57M Series BNew companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Unrivaled $100M Series CinKind $450M GrowthNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Voya Energy $35M Series AHelsing $1.8B Series ENew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Arintra $25M Series BVexev $6M UndisclosedNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Unrivaled $100M Series CWispr Flow $280M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Unrivaled $100M Series CArena $150M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
F4GE Undisclosed SeedNitra $187M Series A+Series B+DebtNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Pixelgen Technologies $15.5M Series BAlpaca $150M Series DNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Pixelgen Technologies $15.5M Series BAlixLabs €15M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 2
Deepentix Undisclosed Pre-seed SAFEAisel Health €1.7M Pre-SeedNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Network Bio $50M StrategicOpenEvidence $250M Series DNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
SnerpaPower €3.4M Seed investment and Vöxtur grantQuanscient €10M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
TravelX Undisclosed Series AClarasight $11.5M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.